Update on antimicrobial agents: new indications of older agents (Q36222046)

12 August 2017

1 reference

title

Update on antimicrobial agents: new indications of older agents (English)

1 reference

12 August 2017

Timothy R Pasquale

1

1 reference

12 August 2017

James S Tan

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

10

1 reference

12 August 2017

page(s)

1681-1691

1 reference

Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Nontuberculous mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Comparison of azithromycin and doxycycline in the treatment of erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Treatment of cat-scratch disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Babesiosis in humans: a treatment review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Atovaquone and azithromycin for the treatment of babesiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Nonantimicrobial effects of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Doxycycline prophylaxis for falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Update on Prevention of Malaria for Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Doxycycline and other tetracyclines in the treatment of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Prospects for neuroprotection in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Treatment of Wegener's granulomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Cyclospora cayetanensis, a food- and waterborne coccidian parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Pharmacologic therapy for stop mutations: how much CFTR activity is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Clindamycin as an antimalarial drug: review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Clindamycin is effective against Plasmodium falciparum but not against P. vivax in mixed infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Fluoroquinolones, tuberculosis, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Fluoroquinolones and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

The Clinical Use of Fluoroquinolones for the Treatment of Mycobacterial Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

The role of fluoroquinolones in tuberculosis today

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.6.10.1681

10.1517/14656566.6.10.1681

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference